Three-time major champion Jordan Spieth knows golf runs on data: ball speed, launch angle, spin rate, and AI that has analyzed millions of swings. So why not use that same intelligence for something that means everything, your health? Caris Detect™ is a multi-cancer early detection test that analyzes your entire genome and transcriptome from a single blood draw. Powered by AI trained on more than 50 billion molecular markers from over 1 million patient cases; it helps find cancer early when treatment is most effective. Some things in life aren’t a game. Stop waiting. Know early. Get the test at CarisDetect.com.

Caris Life Sciences announced the launch of the second commercial in a series promoting Caris Detect™, Caris’ multi-cancer early detection (MCED) test, featuring three-time major champion professional golfer, Jordan Spieth. “Every golfer is looking for an edge. We use technology to measure everything from ball speed to spin rate because better information leads to better decisions. That’s what resonated with me about Caris Detect. If advanced artificial intelligence can help us understand our golf game, it should also help us better understand our health. Raising awareness about the importance of early detection is something I’m proud to support,” said Jordan Spieth. Learn more: ow.ly/2yHs50ZYEhK

MI Cancer Seek® integrates Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) in a single assay to provide comprehensive genomic insights alongside FDA-approved CDx for solid tumors that help inform treatment strategies. Learn more: bit.ly/4lyGNTR

Connect with the Caris Biopharma team at ESMO 2026 to learn how deep molecular insights and real-world clinical data are helping advance cancer research and support the development of new therapies. Learn more: ow.ly/tf6p50ZUEL6 #ESMOAI26

When cancer is found at an early stage, it’s more treatable, and survival rates are at their highest. Caris Detect is a new test that looks for any type of cancer gene in your blood to find it in early-stage, when it matters most. Concerned about your cancer risk? Take a proactive step for your health. Learn more at CarisDetect.com

You shouldn't have to choose between breadth and depth. Caris Assure pairs a 23,000+ gene whole-exome backbone with deeper sequencing focused on therapy-relevant genes, helping clinicians identify actionable alterations from blood. Learn more: bit.ly/4eYqHQO

Caris announced it will report third quarter 2026 financial results on November 4, 2026. Learn more: ow.ly/GgFb50ZXMtm

Connect with Caris at ESMO 2026, find us at booth #1021 or schedule a meeting to learn more about our latest solutions in precision oncology and explore our newly launched product offerings. Schedule a meeting: ow.ly/Wgsr50ZUEzw #ESMOAI26

Researchers from Caris Life Sciences and the Caris Precision Oncology Alliance® (Caris POA) will present eight posters at the European Society for Medical Oncology (ESMO) Congress 2026. The research showcases the expanding impact of artificial intelligence, molecular profiling and multimodal data integration in advancing precision oncology across multiple tumor types. Learn more: ow.ly/Ebwm50ZXoVF

A metastatic breast cancer diagnosis comes with uncertainty. Join Jamie Holloway, PhD, Vice President of Molecular Science Liaisons at Caris Life Sciences, as she shares both personal and professional perspectives on navigating "scanxiety," understanding your cancer's biology and making informed treatment decisions. Register for "Beyond Diagnosis: From Scanxiety to Informed Decisions in mBC:" ow.ly/LnG350ZWYwL

What if "low risk" isn't the full story? One recent case involved a patient with multifocal invasive lobular carcinoma, prior contralateral breast cancer, 10 years of endocrine therapy and a BRCA2 mutation. Despite low early recurrence risk, Caris MI Clarity™ identified elevated late recurrence risk, helping reframe the conversation from short-term reassurance and long-term uncertainty to one that also encompassed long-term planning. Read the case to see how separate early and late risk assessments changed the clinical discussion: ow.ly/lkqb50ZHLrt

1 in 8 women will be diagnosed with breast cancer in their lifetime. When it's caught at a localized stage, the 5-year relative survival rate is around 99%, compared with 32% once it has spread to distant parts of the body. Blood-based cancer tests are not all the same. Caris Detect is the most advanced multiple cancer early-stage detection test ever developed. Learn more and get the test at CarisDetect.com

Jordan Spieth sits down with Caris Life Sciences Founder, Chairman and CEO David Halbert to talk about Caris Detect™, a new test that find signs of early-stage cancer in a patient’s blood, when treatment is most effective. Get the test at CarisDetect.com

Collaboration with Jordan Spieth, three-time major champion professional golfer. Three-time major champion Jordan Spieth sits down with Caris Founder, Chairman and CEO David Dean Halbert to discuss how AI is sharpening athletic performance and advancing early-stage cancer detection. Get the test at CarisDetect.com [Watch the Interview]

Kevin Costner sat down with David Dean Halbert, Founder, Chairman and CEO of Caris Life Sciences for a conversation about why finding cancer early matters. Watch highlights from their conversation: CarisDetect.com

This Breast Cancer Awareness Month, stay informed about breast cancer companion diagnostics and the testing that can help guide treatment. MI Cancer Seek is FDA‑approved to detect PIK3CA mutations in breast cancers to help guide treatment. Learn more about how it supports breast cancer care. More info: ow.ly/iiBZ50ZSHt4

Early Changes Everything. Caris Detect™ helps find cancer when it matters most, at an early stage, when treatment is most effective.  Get the test at CarisDetect.com.

Fragmented genetic testing can limit insight into myeloid malignancies. Caris ChromoSeq consolidates multiple methods into one Whole Genome Sequencing (WGS) assay, delivering a comprehensive view to support diagnosis and risk stratification. Learn more: bit.ly/4ufznZw

Cancer found early is more treatable, and that’s when survival is highest. Caris Detect™ is a blood test designed to find cancer when it matters most. Learn more at CarisDetect.com.